VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
PYXS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
PYXSPyxis Oncology, Inc.
$1.41$89M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksPYXSQuarterly Cash Flow

Pyxis Oncology, Inc. (PYXS) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Pyxis Oncology, Inc. (PYXS) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

PYXS Cash Flow Statement

Quarterly statement

PYXS Cash Flow Statement

Pyxis Oncology, Inc. (PYXS) cash flow statement — 7-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Cash from Operations-16.29M-18.21M-26M-10.43M-13.28M-17.26M-22.54M-19.29M-14.66M-3.01M-20.71M-15.25M-17.58M-11.03M-26.84M-17.39M-20.56M-23.71M-27.68M-12.17M
Operating CF Margin %----94.46%--612.16%-----128.27%---------
Operating CF Growth %-22.72%-5.46%-15.38%45.95%9.46%-474.09%-8.81%-26.46%16.6%72.74%22.84%12.27%14.47%53.48%3.03%-42.88%-182.07%-928.51%-47.77%-284.24%
Net Income-19.98M-25.35M-23.27M-18.11M-22M-18.35M-21.16M-35.57M-21.2M-17.3M-3.26M-15.6M-23.05M-15.9M-19.24M-36.1M-27.67M-25.56M-31.38M-16.83M
Depreciation & Amortization299K301K459K2.9M527K535K552K550K731K585K1.12M690K523K524K190K192K200K159K158K158K
Stock-Based Compensation1.33M5.53M1.21M2.08M3.07M3.02M3.63M2.77M2.98M2.87M4.32M3.21M5.18M3.67M4.88M3.9M4.45M4.01M3.4M3.11M
Deferred Taxes0000000000000-1.26M000000
Other Non-Cash Items-1.06M45K-11K-156K-322K-694K-964K19.62M-1.47M-1.47M-1.12M-1.25M-1.33M175K-463K9.55M307K316K232K566K
Working Capital Changes3.12M1.27M-4.39M2.86M5.45M-1.76M-4.6M-6.66M4.3M12.3M-21.77M-2.31M1.09M1.76M-12.21M5.07M2.16M-2.64M-93K824K
Change in Receivables00000-3M0008M-8M000000000
Change in Inventory00000000000000000000
Change in Payables4.86M-1.72M-5.9M1.13M344K6.57M-2.01M-10K-602K3.18M-1.36M350K-1.54M-1.56M-753K-1.89M-2.31M5.76M-9.9M4.03M
Cash from Investing-37.29M21.3M16.37M16.26M11.47M15.3M15.82M26.66M-8K4K-18.5M10.23M6.57M-22.25M-99.39M-1.86M-4.27M-129K-146K0
Capital Expenditures0000-9K00000-237K0-61K-2.26M-4.41M-1.86M-4.27M-129K-146K0
CapEx % of Revenue----------1.47%---------
Acquisitions000000000001K0-15.19M000000
Investments--------------------
Other Investing63.74M00-107.31M000000006.66M15.19M000000
Cash from Financing38.59M9.99M-25K669K-8K-67K050K1.66M110K57.51M-25K-171K6.13M006K1K176K154.9M
Debt Issued (Net)00000000000000000000
Equity Issued (Net)047K0740K0-67K2K01.48M105K57.46M006.12M00000152.3M
Dividends Paid00000000000000000000
Share Repurchases00000-67K00000000000000
Other Financing38.59M9.95M-25K-71K-8K0-2K50K176K5K49K-25K-171K3K006K1K176K2.6M
Net Change in Cash-15M13.09M-9.66M6.5M-1.81M-2.03M-6.71M7.42M-13.02M-2.89M18.3M-5.05M-11.18M-27.16M-126.23M-19.25M-24.82M-23.84M-27.65M142.73M
Free Cash Flow-16.29M-18.21M-26M-10.43M-13.29M-17.26M-22.54M-19.29M-14.66M-3.01M-20.95M-15.25M-17.64M-13.29M-31.25M-19.25M-24.82M-23.84M-27.82M-12.17M
FCF Margin %----94.46%--612.16%-----129.73%---------
FCF Growth %-22.64%-5.46%-15.38%45.95%9.4%-474.09%-7.58%-26.46%16.88%77.37%32.96%20.74%28.92%44.26%-12.3%-58.15%-240.6%-1057.09%-47.22%-284.24%
FCF per Share-0.20-0.28-0.41-0.17-0.21-0.28-0.37-0.32-0.24-0.05-0.41-0.34-0.43-0.35-0.88-0.55-0.76-0.73-0.86-0.38
FCF Conversion (FCF/Net Income)0.82x0.72x1.12x0.58x0.60x0.94x1.07x0.54x0.69x0.17x6.36x0.98x0.76x0.69x1.39x0.48x0.74x0.93x0.88x0.72x
Interest Paid00000000000000000000
Taxes Paid000000000000028K20K00000